Budecort Rotacaps 200 mcg Cipla
€7.00
Buy Budecort Rotacaps 200 mcg Cipla at the best price, reasons to buy here
Budecort Rotacaps 200 mcg Cipla offers an effective solution for respiratory ailments, making it a preferred choice for athletes and fitness enthusiasts. Purchasing this medication from our site ensures you receive the best price in the market. Our commitment to quality and customer service sets us apart, as we prioritize the well-being of our clients throughout the buying process. Here are a few reasons why you should consider buying Budecort Rotacaps from us:
1. Competitive pricing: We offer Budecort Rotacaps at affordable rates without compromising on quality.
2. Reliable sourcing: Our products are sourced directly from manufacturers like Cipla, ensuring authenticity.
3. Discreet delivery: Enjoy a hassle-free and discreet shipping process right to your doorstep.
4. Customer support: Our dedicated team is always available to assist with inquiries and provide guidance on usage.
General characteristics, composition and activity
Budecort Rotacaps 200 mcg is an inhalable steroid that is formulated to aid individuals suffering from asthma and chronic obstructive pulmonary disease (COPD). The active ingredient, Budesonide, belongs to the class of drugs known as corticosteroids. This medication is available in rotacaps, which are specifically designed for use in a dry powder inhaler. Each rotacap contains 200 mcg of Budesonide, allowing for effective control of respiratory symptoms. The formulation not only aids in reducing inflammation in the airways but also helps in improving overall lung function. Sports enthusiasts who deal with respiratory issues may find this medication particularly beneficial for maintaining their performance during physical activities.
Mechanism of action, biological effect
Budecort acts primarily by binding to glucocorticoid receptors in the respiratory tract. Once attached, Budesonide initiates a series of biological responses that lead to the reduction of inflammation, swelling, and mucus production within the airways. This mechanism enhances the airflow to the lungs, mitigating symptoms such as wheezing, coughing, and shortness of breath. Over time, the consistent use of Budecort can help prevent asthma attacks and ensure athletes can perform at their best without interruption. The systemic absorption of Budesonide is minimal, which contributes to its safety profile, allowing for long-term management of respiratory conditions for many individuals.
- Improved lung function: Regular use results in enhanced airflow and reduced airway resistance.
- Increased exercise tolerance: Athletes can push their limits without the constraint of respiratory issues.
- Reduction in acute symptoms: Effective control over wheezing and coughing, leading to fewer interruptions during sports activities.
- Overall health improvement: Enhanced respiratory health contributes to better overall well-being.
Effects on performance, proven results
Athletes using Budecort Rotacaps have reported significant improvements in their performance levels. Studies indicate that individuals with optimized respiratory function can engage in prolonged and intensive workouts without experiencing discomfort or reduced stamina. The inhalable form allows for rapid relief of respiratory distress, which translates to less downtime due to asthma attacks or other respiratory complications. Many athletes have found that by integrating Budecort into their routine, they can achieve their fitness goals more efficiently. Moreover, the medication’s efficacy in reducing exercise-induced bronchospasm has been documented, making it an essential consideration for any sportsperson dealing with such challenges.
Safety and contraindications, recommendations
While Budecort Rotacaps are generally safe for most individuals, it’s crucial to be aware of potential contraindications and recommendations. Before starting the medication, individuals with the following conditions should consult a healthcare professional:
1. Allergies to Budesonide or any other ingredient in the formulation.
2. History of severe allergic reactions or asthma-related complications.
3. Active infections such as tuberculosis or fungal infections.
4. Individuals taking certain medications that may interact adversely with corticosteroids.
It’s essential to adhere to the prescribed dosage and avoid discontinuation without consulting a physician, as abrupt cessation can lead to a resurgence of symptoms. Regular follow-ups with a healthcare provider can aid in optimizing treatment effectiveness while monitoring potential side effects.
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | Low |
| Lab Test | Not specific for standard drug tests |
| Strength | 200 mcg |
| Also known as | Budesonidum |
| Blood pressure | Typically no effect on blood pressure |
| Trade name | Pulmicort, Rhinocort |
| Storage conditions | Store in a cool, dry place away from direct sunlight |
| Chemical name | (RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde |
| Formula | C25H34O6 |
| Substance class | Corticosteroid |
| Main action | Anti-inflammatory |
| Half-life | 2 to 3.6 hours |
| Dosage (medical) | Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day) |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation, suppresses immune response |
| Side effects | Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression |
| Use in sports | Not commonly used, except for legitimate asthma treatment |
| Manufacturer | Cipla |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |




Reviews
There are no reviews yet.